We described the prevalence of economic-insecurities among 108 prostate cancer survivors and examined the associations between economic-insecurities and patient-reported-outcomes. >40% experienced food and/or income insecurities that were associated with worse patient-reported-outcomes, highlighting the importance of economic insecurities assessment within urological-nursing-practice.
Nadofaragene firadenovec-vncg (Adstiladrin®) is an intravesical nonreplicating adenoviral vector-based gene therapy indicated in high-risk Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer with carcinoma in situ with or without papillary tumors. This review provides nursing considerations regarding nadofaragene firadenovec, including proper storage and handling, administration protocols, monitoring for adverse events, appropriate disposal, and patient education.
